We are live on ! Find out more
CA

Continental Advisors Portfolio holdings

AUM $196M
1-Year Est. Return 24.19%
This Fund
S&P 500
This Quarter Est. Return
+7.73%
1 Year Est. Return
+24.19%
3 Year Est. Return
+67.62%
5 Year Est. Return
+60.86%
10 Year Est. Return
+208.23%
AUM
$358M
AUM Growth
+$33.7M
Cap. Flow
+$17.4M
Cap. Flow %
4.87%
Top 10 Hldgs %
27.79%
Holding
153
New
34
Increased
35
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.01M
2
CVS icon
CVS Health
CVS
+$2.4M
3
WFC icon
Wells Fargo
WFC
+$2.1M
4
TROW icon
T. Rowe Price
TROW
+$1.8M
5
JPM icon
JPMorgan Chase
JPM
+$1.56M

Top Sells

Rank Stock Value
1
CHMI
Cherry Hill Mortgage Investment Corp
CHMI
+$2.8M
2
PROV icon
Provident Financial
PROV
+$2.48M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.94M
4
SNY icon
Sanofi
SNY
+$1.85M
5
KCG
KCG Holdings, Inc.
KCG
+$1.68M

Sector Composition

Rank Sector Weight
1 Financials 31.06%
2 Healthcare 23.03%
3 Consumer Discretionary 1.81%
4 Consumer Staples 1.57%
5 Industrials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
51
Johnson & Johnson
JNJ
$624B
$2.63M 0.74%
22,300
-16,000
-42% -$1.94M
AZN icon
52
AstraZeneca
AZN
$261B
$2.62M 0.73%
39,900
-2,500
-6% -$163K
CYH icon
53
Community Health Systems
CYH
$392M
$2.61M 0.73%
226,400
+52,200
+30% +$602K
CSFL
54
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$2.58M 0.72%
145,291
-29,745
-17% -$509K
DVA icon
55
CALL
DaVita
DVA
$15B
$2.51M 0.7%
38,000
+28,500
+300% +$2.01M
HOLX
56
DELISTED
Hologic
HOLX
$2.4M 0.67%
61,800
– –
CVS icon
57
CVS Health
CVS
$136B
$2.31M 0.65%
26,000
+25,400
+4,233% +$2.4M
GDX icon
58
CALL
VanEck Gold Miners ETF
GDX
$22.9B
$2.11M 0.59%
80,000
-30,000
-27% -$861K
BHC icon
59
Bausch Health
BHC
$1.66B
$2.02M 0.56%
82,100
-13,500
-14% -$349K
UNFI icon
60
United Natural Foods
UNFI
$2.94B
$2.01M 0.56%
50,150
– –
ZTS icon
61
Zoetis
ZTS
$31.3B
$1.91M 0.53%
36,700
– –
MON
62
DELISTED
Monsanto Co
MON
$1.88M 0.53%
18,400
– –
AGN
63
DELISTED
Allergan plc
AGN
$1.87M 0.52%
8,100
+4,400
+119% +$1.08M
FHI icon
64
Federated Hermes
FHI
$4.35B
$1.76M 0.49%
59,385
– –
MDT icon
65
PUT
Medtronic
MDT
$105B
$1.73M 0.48%
+20,000
New +$1.74M
LMAT icon
66
LeMaitre Vascular
LMAT
$2.23B
$1.68M 0.47%
84,900
– –
STT icon
67
State Street
STT
$50.6B
$1.68M 0.47%
24,100
-5,000
-17% -$327K
RVSB icon
68
Riverview Bancorp
RVSB
$107M
$1.65M 0.46%
306,532
– –
AVNS icon
69
Avanos Medical
AVNS
$1.17B
$1.59M 0.45%
46,000
– –
BAC icon
70
CALL
Bank of America
BAC
$430B
$1.56M 0.44%
100,000
– –
WMGI
71
DELISTED
Wright Medical Group Inc
WMGI
$1.55M 0.43%
63,300
– –
MJN
72
DELISTED
Mead Johnson Nutrition Company
MJN
$1.54M 0.43%
19,500
– –
PFE icon
73
PUT
Pfizer
PFE
$143B
$1.49M 0.42%
+46,376
New +$1.55M
RF icon
74
CALL
Regions Financial
RF
$26.2B
$1.48M 0.41%
+150,000
New +$1.4M
TEVA icon
75
Teva Pharmaceuticals
TEVA
$36.3B
$1.47M 0.41%
32,000
– –
1 2
3
4 5

Similar funds

LWA
Legacy Wealth Advisors Miami, Florida $196M AUM
NWA
Navis Wealth Advisors Rye Brook, New York $196M AUM 33.05% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
PAM
Peninsula Asset Management Bradenton, Florida $196M AUM 10.62% 1-Year Est. Return
MAMF
Mirabaud Asset Management (France) Paris, France $196M AUM
SF
SWP Financial San Diego, California $196M AUM 14.56% 1-Year Est. Return
CCP
Cyrus Capital Partners New York $196M AUM 123.68% 1-Year Est. Return
ACM
AUA Capital Management Camp Hill, Pennsylvania $196M AUM 18.71% 1-Year Est. Return

Continental Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Continental Advisors held 153 positions worth $358M, up 10% from $324M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Continental Advisors deployed $17.4M of net new capital in Q3 2016, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was Gilead Sciences: 37,000 shares worth $2.93M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Cherry Hill Mortgage Investment Corp, an estimated $2.8M trimmed.

  • Continental Advisors's largest Q3 2016 buy was Gilead Sciences: 37,000 shares worth $2.93M.
  • Continental Advisors added most to CVS Health in Q3 2016, an estimated $2.4M increase.
  • Continental Advisors's biggest Q3 2016 reduction was Cherry Hill Mortgage Investment Corp, cutting an estimated $2.8M.
  • Continental Advisors fully exited Sanofi in Q3 2016, selling an estimated $1.85M.
  • Continental Advisors's ten largest holdings make up 28% of its $358M portfolio in Q3 2016.
  • Continental Advisors opened 34 new positions and closed 16 in Q3 2016.
  • Continental Advisors's portfolio value rose 10% quarter-over-quarter to $358M.

Based on Continental Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.